BEDFORD, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- (NASDAQ:OCUL, “Ocular”, the “Company”), a biopharmaceutical company ...

Recent Leadership Appointments Put Ocular on Track to Become a Leader in Retinal Care Site Activation and Patient Enrollment for AXPAXLI™ SOL-1 Phase 3 wet AMD Trial Progressing with First Subjects ...

Warning! GuruFocus has detected 3 Warning Signs with OCUL. Ocular Therapeutix Inc (NASDAQ:OCUL) released its 8-K filing on ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Ocular Therapeutix (NASDAQ:OCUL) just reported results for the first quarter ...

Ocular Therapeutix, Inc. (NASDAQ:OCUL) (“Ocular”), a biopharmaceutical company committed to enhancing people’s vision and ...

AHF has launched a new national public awareness campaign using the image of two giant bloodshot, infected eyes and the ...

Ocular Therapeutix will be reporting Q1 earnings on May 7. Analysts on Wall Street predict Ocular Therapeutix will release losses per share of $0.193. Go here to follow Ocular Therapeutix stock price ...

BEDFORD, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL) ("Ocular"), a biopharmaceutical company committed to enhancing people's vision and quality of life through the ...

Friends, family, and supporters got together on Sunday, May 5 at Central Standard Distillery for the Milwaukee Walk for ...

OIS Retina and ARVO meetings are being held in Seattle, WashingtonBEDFORD, Mass., May 03, 2024 (GLOBE NEWSWIRE) -- (NASDAQ:OCUL, “Ocular”, the “Company”), a biopharmaceutical company committed to ...